Origin & tradition
Not traditional: GlyNAC is a research-driven combination targeting age-related glutathione decline.
Western tradition · Glutathione precursors
A glutathione-restoring amino-acid pair with promising small trials on oxidative stress and aging markers.
Data definition. Matched records include all indexed medical endpoints for this intervention — not only longevity. Longevity-relevant records are screened separately and cited in the evidence summary below. Counts are matched-record volumes, not de-duplicated trials and not efficacy claims.
Not traditional: GlyNAC is a research-driven combination targeting age-related glutathione decline.
Key active: Glycine + N-acetylcysteine.
Glycine and N-acetylcysteine restore glutathione synthesis; small randomized and pilot trials in older adults report improved oxidative stress, mitochondrial function, strength, and cognition — promising but early.
Effect summary
| Health outcome | Effect | Magnitude | Grade |
|---|---|---|---|
| Glutathione levels | Increases | Strong | B |
| Oxidative stress markers | Decreases | Strong | B |
| Mitochondrial function markers | Increases | Moderate | B |
| Muscle strength (elderly) | Increases | Moderate | C |
| Cognitive function (elderly) | Increases | Moderate | C |
| Biological age markers | Decreases | Minor | C |
Grade: A = robust RCTs · B = several RCTs / meta-analysis · C = limited or mixed RCTs · D = observational or early data
Dosage guidance
GlyNAC is a combination, not a single compound. Both precursors are needed for glutathione synthesis. Baylor College of Medicine trials (Dr. Sekhar) are the primary evidence base. Can be taken as separate supplements — no need for a branded product.
Informational only — not a prescription or personalised medical advice. Consult a qualified clinician before starting any supplement or medication.
Evidence summary
Small human RCT/pilot data; glutathione mechanism
Glycine and N-acetylcysteine restore glutathione synthesis; small randomized and pilot trials in older adults report improved oxidative stress, mitochondrial function, strength, and cognition — promising but early.
According to PubMed and ClinicalTrials.gov: trial counts from ClinicalTrials.gov, peer-reviewed literature from PubMed. Counts auto-refresh weekly; last checked 2026-07-19. They include trials across many endpoints, not only longevity.
Informational only — not medical advice, a treatment claim, or a substitute for a qualified clinician. Evidence strength varies; we show mixed and null results on purpose.
Evidence collections
Compare the evidence
The mitochondrial electron carrier that declines with age and statin use — with cardiovascular trial support.
A mitochondrial cofactor active in both fat and water — the only antioxidant that regenerates glutathione, vitamin C, and vitamin E simultaneously.
A gut-derived metabolite that triggers mitophagy — with human trials on muscle and mitochondrial function.
The most potent known NRF2 activator, from broccoli, with human trials in cancer chemoprevention and neuroprotection.
Suppliers
Tell us what you need and we will source suppliers for you.